Leading Pharmaceutical CDMO/CRDMO trusted partner

Meet the Cohance CDMO Team at

Booth #84 | September 15-17, 2026 | Boston, MA

Book A Meeting

Meet Our CDMO and API+ Experts at

Book A Meeting

October 6 - 8, 2026 | Fiera Milano, Italy

Multi-Modality Expertise.
One Trusted CDMO Partner.

A global CDMO platform specialized in ADCs, Nucleic Acid Chemistry, and Small Molecules.

Discover More

Collaborate. Enhance. Deliver.

Accelerating your pipeline with reliable, integrated CDMO support.

Discover More

Nucleic Acid Expertise.
Smarter Therapeutic Design.

With deep capabilities in phosphoramidite chemistry and nucleoside modification, we help innovators optimize synthesis and scale.

Discover More

ADC Innovation.
Integrated CRDMO Capabilities.

From discovery to commercial scale, we streamline ADC development through chemistry, bioconjugation, and manufacturing excellence.

Discover More

We are cutting emissions, expanding renewable energy, and reducing water use. And our progress is affirmed by an Ecovadis Gold rating.

Our ESG Goals & Aspirations
Towards Shaping a Sustainable Future

Discover More

How Can We Collaborate…

Cohance at a Glance

1 +

Decades CDMO Experience

2 +

Innovator
Relationships

1 +

Years Average Partnership

1 +

CDMO Projects Executed

Commercial
Molecules

1 +

Decades CDMO Experience

1 +

Innovator
Relationships

1 +

Years Average Partnership

1 +

CDMO Projects Executed

Commercial
Molecules

R&D
Centres

1 +

Scientists

Manufacturing
Sites

USFDA/EDQM Accredited Sites

1 + KL

Reactor
Capacity

Sustainability at Cohance

Responsibility for community and the environment

At Cohance, caring for the planet is integral to caring for humanity. And our commitment to sustainability goes beyond compliance.

Supplier Since 2013

Gold Award

Merit Award
2026

B Rating

Validated

Inside Cohance